Researchers push forward on new Alzheimer's tests, treatments

Researchers are developing new diagnostic and treatment options for Alzheimer's disease, including Amyvid, a radioactive dye used with imaging scans to rule out the degenerative disease, and other tests that track tangles of protein in the brain that may be a sign of the dementia. There are five drugs approved to treat Alzheimer's disease but they have had limited success, so researchers are shifting their focus to see whether the medications may prevent the disease in at-risk individuals.

View Full Article in:

Washington Post (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Pompano Beach, FL